Physician profile
Aaron C Studer
NPI 1427104389
$1,553.30
in general payments reported to CMS, 2019-2025
11 companies · $17.04 in 2025
The $17.04 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $766 · 2020: $100 · 2021: $31.39 · 2022: $52.34 · 2023: $358 · 2024: $229 · 2025: $17.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $603.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ivoclar Vivadent, INC. | $508.05 | 2019 | |
| Zimvie INC. | $336.53 | 2022-2024 | |
| Dentsply Sirona INC | $239.72 | 2019-2025 | Astra Tech Implant System, Suresmile |
| Patterson Companies, INC. | $152.11 | 2019-2023 | |
| Solventum Corporation | $85.37 | 2024 | Filtek, 3m Filtek, Clarity Aligners |
| Zimmer Biomet Holdings, INC. | $71.32 | 2019-2021 | |
| Kerr Corporation | $47.29 | 2023 | Zirconia Abutment Preparation Kit |
| Nobel Biocare USA | $47.29 | 2023 | Nobelactive |
| Sonendo INC | $35.83 | 2019 | |
| Dentsply Sirona Orthodontics INC | $17.58 | 2019 | |
| Elevate Oral Care | $12.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Studer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.